{"schema_version":"secwatch.filing_event.v1","accession":"0000355019-23-000009","form_type":"8-K","ticker":"FONR","cik":"0000355019","company_name":"FONAR CORP","filed_at":"2023-02-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.631770+00:00","generated_at":"2026-06-19T12:22:10.484844+00:00","sec_items":["2.02"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"FONAR Q2 net income falls 45%; revenue down 1% to $24.3M","bullets":["Q2 revenue $24.3M (-1% YoY); six-month revenue $47.4M (-2% YoY).","Q2 net income $2.8M (-45%); diluted EPS $0.32 (-44%).","Income from operations Q2 $4.2M (-35%); six-month $8.1M (-33%).","MRI scan volume at HMCA-managed sites 89,888 (-5%); SG&A up 31% to $12.9M.","Cash and investments $49.5M; book value per share $22.25 (+4%); repurchased 53,607 shares for $922,593."],"urls":{"canonical":"https://secwatch.observer/filing/0000355019-23-000009","json":"https://secwatch.observer/filing/0000355019-23-000009.json","markdown":"https://secwatch.observer/filing/0000355019-23-000009.md","text":"https://secwatch.observer/filing/0000355019-23-000009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/355019/000035501923000009/0000355019-23-000009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/355019/000035501923000009/fonar_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T12:22:10.484844+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b24cc24f2468437ee7e9a7796c9e3cd79e657fa6","claim":"FONAR CORP reported for the fiscal 2023 six month period ended December 31, 2022 and quarter ended December 31, 2022 results: revenue $47.4 million for the six months ended December 31, 2022; $24.3 million for the quarter ended December 31, 2022, net income $5.5 million for the six months ended December 31, 2022; $2.8 million for the quarter ended December 31, 2022, EPS $0.60 per diluted share for the six months ended December 31, 2022; $0.32 per diluted share for the quarter ended Decemb.","evidence_excerpt":"FONAR Corporation (NASDAQ-FONR), The Inventor of MR ScanningTM, reported today its financial results for the fiscal 2023 six month period and quarter ended December 31, 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/355019/000035501923000009/0000355019-23-000009-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"for the fiscal 2023 six month period ended December 31, 2022 and quarter ended December 31, 2022"},{"label":"Revenue","value":"$47.4 million for the six months ended December 31, 2022; $24.3 million for the quarter ended December 31, 2022"},{"label":"Net income","value":"$5.5 million for the six months ended December 31, 2022; $2.8 million for the quarter ended December 31, 2022"},{"label":"EPS","value":"$0.60 per diluted share for the six months ended December 31, 2022; $0.32 per diluted share for the quarter ended Decemb"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}